Net sales were 30,172 million yen (Year-over-Year -0.7%), and operating income was 2,178 million yen (YoY -31.0%), both decreased. While medical and healthcare devices drove revenue and profit growth, the semiconductor-related segment saw a large decline in revenue and an operating loss due to demand adjustments. The full-year forecast has been previously revised and published. A negative goodwill gain of 242 million yen was recorded as an extraordinary gain due to the newly consolidated subsidiary ADC.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7745","jir_company_name":"A&D HOLON Holdings Company, Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7745-20261106-01.pdf","jir_short_summary":"Net sales were 30,172 million yen (Year-over-Year -0.7%), and operating income was 2,178 million yen (YoY -31.0%), both decreased. While medical and healthcare devices drove revenue and profit growth, the semiconductor-related segment saw a large decline in revenue and an operating loss due to demand adjustments. The full-year forecast has been previously revised and published. A negative goodwill gain of 242 million yen was recorded as an extraordinary gain due to the newly consolidated subsidiary ADC.","jir_summary":"### Overview of Results\nNet sales for the period were 30,172 million yen (YoY -0.7%), effectively flat overall, but with divergent movements by segment. The semiconductor-related segment recorded a decline in revenue and an operating loss due to demand adjustments. In contrast, measurement and weighing instruments and medical and healthcare devices achieved higher revenue and profit. In particular, medical and healthcare devices performed strongly due to expanded overseas demand, currency effects, and tariff refund benefits. Following the acquisition of the newly consolidated subsidiary ADC, a negative goodwill gain of 242 million yen was recorded as an extraordinary gain.\n\n### Full-Year Outlook and Financial Position\nTotal assets at interim period-end were 76,412 million yen, and net assets were 50,190 million yen. For the full-year outlook, refer to the separate notice titled \"Notice Regarding Differences Between Forecasts and Results for the Six Months Ended March 2027 and Revisions to Full-Year Forecasts for the Year Ending March 2027.\" The equity ratio remains stable at 65.6%. Note the expanded consolidation scope due to the new subsidiary and pay attention to accounting policy applications such as goodwill treatment.","jir_financial_highlights":"Net Sales: 30,172 (YoY -0.7%)\nOperating Income: 2,178 (YoY -31.0%)\nOrdinary Income: 2,273 (YoY -31.7%)\nNet Income Attributable to Owners of Parent (Interim): 1,666 (YoY -2.2%)\nNew Consolidated Subsidiary: ADC (Recorded a negative goodwill gain of 242 million yen as an extraordinary gain)","jir_category":"","jir_hashtags":"#A&DHOLONHoldings, #Earnings, #InterimResults, #BySegment, #MedicalDevices","jir_key_figures":"Net Sales: 30,172 million yen\nOperating Income: 2,178 million yen\nOrdinary Income: 2,273 million yen","jir_meta_title":"A&D HOLON Holdings Company, Limited - Financial Summary for Six Months Ended March 2027 | Net Sales 30,172 million yen, Operating Income 2,178 million yen","jir_meta_description":"Financial summary for A&D HOLON Holdings Company, Limited for the six months ended March 2027. Summarizes net sales, operating income, ordinary income trends, segment performance, financial position, and revisions to the full-year outlook. Includes impact of the newly consolidated subsidiary and future outlook.","jir_og_title":"A&D HOLON Holdings Company, Limited - Financial Summary for Six Months Ended March 2027","jir_og_description":"Net sales 30,172 million yen, operating income 2,178 million yen. Contrasting decline in semiconductor-related business and strength in medical devices. Notes impact of newly consolidated subsidiary and revisions to full-year forecasts.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[30172,30381,?]}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[215? , 317? , 2178]}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue by Business\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Semiconductor-related\\\",\\\"Measurement & Weighing Instruments\\\",\\\"Medical & Healthcare Devices\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[1279,14925,13967]}]}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026Interim\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[?]}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Full-Year Forecasts: Original vs Revised\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{}}\"}]","ir_related_company":17190,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-144161","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n